LABA safety studies for asthma saw no increased risk in Advair or Symbicort
www.pulmccm.org
After the Serevent Nationwide Surveillance (SNS) and SMART trials both appeared to link the use of long-acting beta agonists (LABAs) to an increased risk of asthma-related death, routine asthma care got scary.
LABA safety studies for asthma saw no increased risk in Advair or Symbicort
LABA safety studies for asthma saw no…
LABA safety studies for asthma saw no increased risk in Advair or Symbicort
After the Serevent Nationwide Surveillance (SNS) and SMART trials both appeared to link the use of long-acting beta agonists (LABAs) to an increased risk of asthma-related death, routine asthma care got scary.